Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Novel antiangiogenic therapies for renal cell cancer.

Novel antiangiogenic therapies for renal cell cancer. Clin Cancer Res. 2004 Sep 15; 10(18 Pt 2):6377S-81S.

View in: PubMed

© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.